Biomerica, Inc. (NASDAQ:BMRA) Sees Large Decrease in Short Interest

Biomerica, Inc. (NASDAQ:BMRAGet Free Report) was the recipient of a large drop in short interest in November. As of November 15th, there was short interest totalling 371,700 shares, a drop of 33.9% from the October 31st total of 562,400 shares. Based on an average daily volume of 442,900 shares, the days-to-cover ratio is currently 0.8 days.

Institutional Trading of Biomerica

An institutional investor recently bought a new position in Biomerica stock. Perritt Capital Management Inc bought a new position in shares of Biomerica, Inc. (NASDAQ:BMRAFree Report) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 70,000 shares of the company’s stock, valued at approximately $31,000. Perritt Capital Management Inc owned 0.42% of Biomerica as of its most recent SEC filing. 22.28% of the stock is owned by institutional investors and hedge funds.

Biomerica Trading Up 6.4 %

Shares of BMRA stock opened at $0.32 on Friday. The business’s fifty day moving average is $0.33 and its 200-day moving average is $0.40. Biomerica has a 1 year low of $0.24 and a 1 year high of $2.13.

Biomerica (NASDAQ:BMRAGet Free Report) last issued its quarterly earnings results on Tuesday, October 15th. The company reported ($0.08) EPS for the quarter. Biomerica had a negative return on equity of 84.62% and a negative net margin of 111.89%. The business had revenue of $1.81 million during the quarter.

About Biomerica

(Get Free Report)

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.

Further Reading

Receive News & Ratings for Biomerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomerica and related companies with MarketBeat.com's FREE daily email newsletter.